Monthly Stock Report: Walgreens Boots Alliance, Inc. (WBA)
Publication Date: September 22, 2024
Company Overview
Walgreens Boots Alliance, Inc. (WBA), headquartered in Deerfield, Illinois, stands as a prominent player in the healthcare and retail sectors, primarily serving markets in the United States, United Kingdom, and Germany. Established in 1909, the company operates through three segments: U.S. Retail Pharmacy, which encompasses retail drugstores and wellness services; International, focusing on pharmacy-led retail outside the U.S.; and U.S. Healthcare, providing value-based care through VillageMD and specialty pharmacy services. As a key entity in the pharmaceutical retail industry, Walgreens Boots Alliance is classified under the Consumer Staples sector and the Drug Retail sub-industry, contributing to the industry’s impressive total revenues of approximately $145.5 billion.
Market Performance
Currently, WBA’s stock is priced at $8.71, significantly below both its fifty-day moving average of $10.34 and its fifty-two week high of $27.05. With a target high price set at $19.00 and a target low price at $7.00, analysts have established an average target mean price of $11.59. This range indicates a diverse outlook among analysts, emphasizing caution in investment decisions. The recommendation is primarily a “hold,” with a score average of 3.1 from 15 analysts, suggesting that existing investors should maintain their positions. Additionally, a noteworthy 13.18% of the company’s float, or about 82.9 million shares, is currently shorted, reflecting market skepticism about growth potential.
Financial Insights
Walgreens Boots Alliance reports total revenues of approximately $145.53 billion, confirming a robust revenue stream. However, the lack of available EBITDA data may pose challenges in evaluating the company’s operational performance comprehensively. Despite its current challenges, analysts project potential value increases for the stock. The current price of $8.71 reveals how the stock trades near its fifty-two week low of $8.46, indicating volatility and uncertainty in market sentiment. Investors should carefully consider the company’s financial performance and analyst recommendations when influencing their investment strategies going forward.
| Metric | Value |
|---|---|
| Market Cap | $7.5b |
| Total Debt | $33.7b |
| Total Cash | $711.0m |
| Shares Outstanding | 863.3m |
| Float Shares | 714.5m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.